You are here

  • Home
  • Archive
  • Volume 11, Issue 8
  • Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3

Article metrics

Article menu
Immune cell therapies and immune cell engineering
Original research
Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3

 

Online download statistics by month:

Online download statistics by month: August 2023 to January 2026

AbstractFullPdf
Aug 202317717720
Sep 2023544546435
Oct 2023385385178
Nov 202324824895
Dec 202321621782
Jan 2024168168117
Feb 202419519589
Mar 202425425587
Apr 2024270271103
May 2024279280130
Jun 202423523591
Jul 2024262262105
Aug 2024257257122
Sep 2024133134261
Oct 2024231231162
Nov 202426626885
Dec 202423023272
Jan 202521121169
Feb 2025166166147
Mar 202520220263
Apr 202513713779
May 202519519574
Jun 202514614640
Jul 2025110
Sep 2025660
Jan 2026001
Total541454252707